Xiamen Amoytop Biotech Co., Ltd. (SHA: 688278)

Xiamen Amoytop Biotech Revenue

Xiamen Amoytop Biotech had revenue of 764.90M CNY in the quarter ending September 30, 2024, with 37.52% growth. This brings the company's revenue in the last twelve months to 2.60B, up 40.78% year-over-year. In the year 2023, Xiamen Amoytop Biotech had annual revenue of 2.10B with 37.55% growth.

• Revenue (ttm): 2.60B
• Revenue Growth: +40.78%
• P/S Ratio: 11.53
• Revenue / Employee: 1.32M
• Employees: 1,960
• Market Cap: 29.90B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.10B	573.42M	37.55%
Dec 31, 2022	1.53B	394.68M	34.86%
Dec 31, 2021	1.13B	338.29M	42.61%
Dec 31, 2020	793.93M	64.27M	8.81%
Dec 31, 2019	729.67M	281.38M	62.77%